A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia
Clinical trial NCT00604279 · COMPLETED
Trial details
- NCT number
- NCT00604279
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-01-01
- Enrollment
- 452
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.